Pharmafile Logo
Pharmafocus logo
Advanced Search
novartissunlight_copy

Novartis’s secukinumab meets Phase 3 goals

October 1, 2015
Research and Development Novartis, Secukinumab, arthritis

Novartis has announced that its secukinumab medication for treatment of psoriatic arthritis (PsA), met its primary endpoint in the pivotal …

News
sayana_press_and_pack

Pfizer’s self-injectable contraceptive becomes UK’s first

September 30, 2015
Medical Communications, Research and Development, Sales and Marketing Pfizer, Syayana Press

Pfizer’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the UK for administration by self-injection following …

News
novartis

Study shows Novartis’s Afinitor positively reduces tumors

September 30, 2015
Research and Development Afinitor, Novartis

Novartis has announced the results of a Phase III pivotal study, showing Afinitor (everolimus) tablets reduced the risk of progression …

News

Genentech’s ocrelizumab shows efficacy in phase III trial

September 30, 2015
Research and Development Genentech, MS, Roche, ocrelizumab

Roche subsidiary Genentech has announced positive results from a pivotal phase III study of its investigational medicine ocrelizumab in people …

News
heptares_logo

Heptares awarded $5.5 million grant to combat cocaine addiction

September 30, 2015
Research and Development Heptares

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, has been awarded a grant from the National Institute …

News

Roche says Esbriet shown to extend lives of IPF patients

September 30, 2015
Medical Communications, Research and Development, Sales and Marketing Esbriet, Roche, idiopathic pulmonary fibrosis

Roche has presented new clinical data and abstracts on Esbriet (pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF), showing …

News
US flag

Featured market report: US pharmaceutical market to 2018

September 29, 2015
Manufacturing and Production, Sales and Marketing market reports

This report forecasts US pharmaceutical (prescription and over-the-counter) shipments and demand at the manufacturers’ level, to 2018.This industry forecast report …

Feature
asthma inhalers

New study reveals true impact of severe asthma in Europe

September 29, 2015
Research and Development ERS2015, asthma

The results of a new, comprehensive survey have revealed the true burden of severe asthma faced by patients across Europe. …

News
3D printer

It’s finally here: 3D-printed pills and technology in pharma

September 29, 2015
Manufacturing and Production 3-D printing, 3d printing, Aprecia, Spritam, manufacturing, production

The notion of tailor-made drugs, which are customised to an individual patient’s needs, has seen remarkable progress of late. This …

Feature

Georges Gemayel appointed non-executive chairman of Enterome

September 29, 2015
Manufacturing and Production

Drug and diagnostics development firm Enterome Bioscience SA has appointed Dr Georges Gemayel to the Enterome board as a non-executive …

Appointment
Michel Sidibe

UN calls on pharma industry to make medicines more affordable

September 29, 2015
Manufacturing and Production AIDS, HIV, Michel Sidibe, UNAIDS, United Nations, antiretroviral treatments

The United Nations AIDS agency, UNAIDS, has called on governments and the pharmaceutical industry to ensure that medicines remain accessible …

News
Sun Pharma logo

FDA withdraws approval for Sun Pharma’s epilepsy drug

September 29, 2015
Manufacturing and Production Elepsia, FDA, Sun Pharma, epilepsy, levetiracetam, manufacturing, productions, seizures

Manufacturing problems at Sun Pharma’s production site has led the FDA to revoke the company’s approval for Elepsia XR for …

News
Opdivo

Bristol-Myers Squibb notches kidney cancer first with Opdivo

September 28, 2015
Research and Development Afinitor, Bristol-Myers Squibb, Kidney cancer, advanced kidney cancer, everolimus, nivolumab, opdivo, renal cell carcinoma

Bristol-Myers Squibb has announced positive results from a Phase III study comparing Opdivo to Afinitor, the Novartis treatment that is …

News
Soliris

Alexion to challenge Canadian price of Soliris in court

September 28, 2015
Sales and Marketing Alexion, Canada, Drug pricing, Patented Medicine Prices Review Board, eculizumab, soliris

Alexion Pharmaceuticals is taking the Canadian government to court for its attempt to lower the price of the rare disease …

News
Praluent

Sanofi and Regeneron given European nod for Praluent

September 28, 2015
Sales and Marketing European Commission, Regeneron, Sanofi, alirocumab, high cholesterol, marketing authorisation, praluent

The European Commission (EC) has approved the marketing authorisation of Sanofi and Regeneron’s cholesterol drug Praluent.  The heart drug is …

News
Novo Nordisk building

FDA approves Novo Nordisk’s diabetes drugs

September 28, 2015
Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin

The FDA has approved two Novo Nordisk drugs, Tresiba and Ryzodeg, for the treatment of type 2 diabetes in adults.The …

News
Sanofi reception

Brandicourt set to continue Sanofi restructure

September 28, 2015
Sales and Marketing Merial, Sanofi, olivier brandicourt, restructuring, sales, spin-off

Sanofi chief executive Olivier Brandicourt is considering sales or spin-offs of a number of the company’s divisions, as part of …

News
law

Legal analysis: compliance top of the agenda for big pharma

September 25, 2015
Medical Communications, Sales and Marketing lawyers, legal, pharma industry, reputation

Do you think big pharma suffers from a negative image, and if so, to what extent do you think this …

Feature

Synergy Vision shortlisted for Women of the Future awards

September 25, 2015
Medical Communications Synergy Vision, medical communications, medical communications agency, women, women of the future awards

Synergy Vision has been shortlisted for the Women of the Future (“WOF”) Awards, the movement recognising and nurturing young female …

News
Press release
glioblastoma

ImmunoCellular awarded $19.9 million grant for ICT-107 phase 3 trial for glioblastoma

September 25, 2015
Research and Development California Institute for Regenerative Medicine, Cancer, ICT-107, brain cancer, glioblastoma

ImmunoCellular Therapeutics has been awarded a $19.9 million grant by California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026